8-K/A

AMENDMENT TO CURRENT REPORT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: November 22, 2011
Period of Report: November 22, 2011
Accession Number: 0001206774-11-002642

View Document ↗ View on SEC.gov ↗